Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trial

AbstractAims. The role of diuretics in patients with intermediate-risk pulmonary embolism (PE) is controversial. In this multicentre, double-blind trial, we ran

Read the full article here

Related Articles